Precision medicine: New paradigms, risks, and opportunities

Source: Knowledge@Wharton — SAP; September 2016

Precision medicine offers some exciting new opportunities in drug development and patient care. But, it is not without challenges, including those that suggest our industry may need to change some of our existing business models. An article by Knowledge@Wharton — SAP takes an in-depth look at the status of precision medicine, and outlines areas that we should watch. Therapy area applications include personalized cancer diagnoses, Alzheimer’s disease, and diabetes, among others. Challenges to the status quo suggest incompatibility with the current reimbursement model and the FDA’s requirements for new drug approvals.

To view the full article, please click on the link below:  [mepr-show if=”rule: 4078″]


[mepr-hide if=”rule: 4078″]

[mepr-show if=”loggedin”]

Your subscription has expired. To view this content, please visit your account page to purchase a new subscription.


[mepr-show if=”loggedout”]

Please login or purchase a membership to view this content.




Stay Connected with MAPS

Join MAPS on LinkedIn to further build your professional connections within Medical Affairs through our Company and Group Pages.

Follow us on Twitter and say abreast of MAPS activities and key issues for Medical Affairs professionals.